scholarly article | Q13442814 |
P50 | author | Hua Fan-Minogue | Q48975673 |
P2093 | author name string | Carmel T Chan | |
Sanjiv S Gambhir | |||
Tarik F Massoud | |||
Ramasamy Paulmurugan | |||
Dean W Felsher | |||
Zhongwei Cao | |||
P2860 | cites work | Molecular imaging in drug development | Q22122025 |
Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts | Q24292464 | ||
Locating a protein-protein interaction in living cells via split Renilla luciferase complementation | Q24300225 | ||
Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals | Q24563431 | ||
Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo | Q24797399 | ||
Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition | Q27633064 | ||
Nursing some sense out of Myc. | Q33508688 | ||
Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation | Q33591386 | ||
The interaction between Myc and Miz1 is required to antagonize TGFbeta-dependent autocrine signaling during lymphoma formation and maintenance | Q33913197 | ||
Molecular imaging of the efficacy of heat shock protein 90 inhibitors in living subjects | Q34096497 | ||
Noninvasive imaging of protein-protein interactions in living subjects by using reporter protein complementation and reconstitution strategies | Q34388172 | ||
Identification of small molecules that induce apoptosis in a Myc-dependent manner and inhibit Myc-driven transformation | Q34536441 | ||
Modelling Myc inhibition as a cancer therapy | Q34811008 | ||
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. | Q35204486 | ||
Combinatorial library screening for developing an improved split-firefly luciferase fragment-assisted complementation system for studying protein-protein interactions | Q35414662 | ||
Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis | Q36007575 | ||
The c-Myc target gene network | Q36564217 | ||
The Myc oncoprotein as a therapeutic target for human cancer | Q36578165 | ||
Mechanism of transcriptional activation by the Myc oncoproteins | Q36578696 | ||
Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function | Q36580032 | ||
Why myc? An unexpected ingredient in the stem cell cocktail | Q37121057 | ||
Reflecting on 25 years with MYC. | Q37333643 | ||
Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter | Q38294087 | ||
HIF-dependent antitumorigenic effect of antioxidants in vivo | Q40085629 | ||
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells | Q40572608 | ||
Monitoring Protein−Protein Interactions Using Split Synthetic Renilla Luciferase Protein-Fragment-Assisted Complementation | Q40653800 | ||
A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation | Q40795858 | ||
Imaging 26S proteasome activity and inhibition in living mice | Q44486478 | ||
Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. | Q45861628 | ||
Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas. | Q54757490 | ||
Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas | Q55670934 | ||
Uncoupling of genomic instability and tumorigenesis in a mouse model of Burkitt's lymphoma expressing a conditional box II-deleted Myc protein | Q61053582 | ||
Ubiquitination of Myc: proteasomal degradation and beyond | Q63407024 | ||
Alterations of c-myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells | Q72611015 | ||
P433 | issue | 36 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 15892-15897 | |
P577 | publication date | 2010-08-16 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Noninvasive molecular imaging of c-Myc activation in living mice | |
P478 | volume | 107 |
Q34793715 | A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide. |
Q37905334 | Bioluminescence imaging: progress and applications |
Q37577301 | Fast and robust reconstruction for fluorescence molecular tomography via a sparsity adaptive subspace pursuit method |
Q36840350 | Fluorescence imaging of in vivo miR-124a-induced neurogenesis of neuronal progenitor cells using neuron-specific reporters |
Q35072414 | Fluorescent biosensors for high throughput screening of protein kinase inhibitors. |
Q43983077 | Imaging mouse cancer models in vivo using reporter transgenes |
Q26851635 | Luciferase fragment complementation imaging in preclinical cancer studies |
Q34687185 | MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase |
Q41565021 | Noninvasive Imaging of Ras Activity by Monomolecular Biosensor Based on Split-Luciferase Complementary Assay |
Q35945748 | Novel Bioluminescent Activatable Reporter for Src Tyrosine Kinase Activity in Living Mice |
Q38227133 | Split-luciferase complementary assay: applications, recent developments, and future perspectives |
Q38601645 | Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis. |
Q36557855 | Targeting tumor metastases: Drug delivery mechanisms and technologies |
Q26742117 | The Expanding Toolbox of In Vivo Bioluminescent Imaging |
Q37871875 | The challenges of integrating molecular imaging into the optimization of cancer therapy. |
Q35614045 | Visualizing protein partnerships in living cells and organisms |
Search more.